Markets.News
U.S. FTC: REQUIRING AUROBINDO PHARMA LIMITED TO DIVEST FOUR DIFFERENT GENERIC DRUG PRODUCTS TO COMPLETE ITS $250 MLN ACQUISITION OF LANNETT COMPANY